- Stocks
- Healthcare
- NYSE: RVTY

Price (delayed)

$115.22

Market cap

$14.45B

P/E Ratio

15.12

Dividend/share

$0.28

EPS

$7.62

Enterprise value

$16.7B

PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique

The quick ratio has soared by 183% QoQ and by 52% YoY

The EPS has soared by 69% from the previous quarter and by 24% YoY

The gross profit has contracted by 23% YoY and by 5% from the previous quarter

The company's revenue fell by 18% YoY

What are the main financial stats of RVTY

Market
Valuations
Earnings

Shares outstanding

125.44M

Market cap

$14.45B

Enterprise value

$16.7B

Price to earnings (P/E)

15.12

Price to book (P/B)

1.81

Price to sales (P/S)

4.33

EV/EBIT

14.32

EV/EBITDA

10.56

EV/Sales

4.97

Revenue

$3.36B

EBIT

$1.17B

EBITDA

$1.58B

Free cash flow

$382.91M

Per share
Balance sheet
Liquidity

EPS

$7.62

Free cash flow per share

$3.03

Book value per share

$63.55

Revenue per share

$26.59

TBVPS

$38.31

Total assets

$14.64B

Total liabilities

$6.6B

Debt

$4.51B

Equity

$8.03B

Working capital

$2.23B

Debt to equity

0.56

Current ratio

2.43

Quick ratio

1.95

Net debt/EBITDA

1.42

Margins
Efficiency
Dividend

EBITDA margin

47.1%

Gross margin

56.3%

Net margin

28.6%

Operating margin

17.1%

Return on assets

6.8%

Return on equity

13%

Return on invested capital

18.3%

Return on capital employed

8.9%

Return on sales

34.7%

Dividend yield

0.24%

DPS

$0.28

Payout ratio

3.7%

How has the Revvity stock price performed over time

Intraday

-0.39%

1 week

-1.24%

1 month

-10.49%

1 year

-23.62%

YTD

-17.83%

QTD

-13.54%

How have Revvity's revenue and profit performed over time

Revenue

$3.36B

Gross profit

$1.89B

Operating income

$575.23M

Net income

$961.69M

Gross margin

56.3%

Net margin

28.6%

Revvity's net income has surged by 69% QoQ and by 30% YoY

RVTY's net margin has soared by 66% since the previous quarter and by 57% year-on-year

The company's operating income fell by 47% YoY and by 23% QoQ

The company's operating margin fell by 36% YoY and by 24% QoQ

What is Revvity's growth rate over time

What is Revvity stock price valuation

P/E

15.12

P/B

1.81

P/S

4.33

EV/EBIT

14.32

EV/EBITDA

10.56

EV/Sales

4.97

The EPS has soared by 69% from the previous quarter and by 24% YoY

The stock's price to earnings (P/E) is 55% less than its 5-year quarterly average of 33.8 and 39% less than its last 4 quarters average of 24.9

The price to book (P/B) is 47% lower than the 5-year quarterly average of 3.4 and 21% lower than the last 4 quarters average of 2.3

The equity is up by 12% year-on-year and by 9% since the previous quarter

The company's revenue fell by 18% YoY

The price to sales (P/S) is 8% lower than the last 4 quarters average of 4.7

How efficient is Revvity business performance

The company's return on assets has surged by 70% QoQ and by 24% YoY

RVTY's return on equity has surged by 65% since the previous quarter and by 12% year-on-year

RVTY's return on invested capital has surged by 53% since the previous quarter and by 7% year-on-year

The ROS has grown by 44% from the previous quarter and by 29% YoY

What is RVTY's dividend history

DPS

$0.28

Dividend yield

0.24%

Payout ratio

3.7%

Recent dividends

How did Revvity financials performed over time

The total assets is 122% greater than the total liabilities

The quick ratio has soared by 183% QoQ and by 52% YoY

The current ratio has grown by 25% YoY and by 14% from the previous quarter

RVTY's debt is 44% smaller than its equity

RVTY's debt to equity is down by 20% year-on-year and by 10% since the previous quarter

The equity is up by 12% year-on-year and by 9% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.